SAML · OIDC · SCIM
Enterprise identity federation, controlled provisioning and lifecycle management belong at the organisation boundary.
NeuraOps is being designed around vendor-neutral integration patterns for identity, clinical data exchange, imaging and workflow events. This prototype describes the integration architecture; it does not expose live production endpoints.
Enterprise identity federation, controlled provisioning and lifecycle management belong at the organisation boundary.
Modern healthcare exchange patterns are treated as adapters into a stable internal operating model rather than hard-coded product dependencies.
Imaging workflows are designed around established standards while preserving provenance, source identity and clinical boundaries.
Operational events, state transitions and acknowledgement signals can move through controlled integration channels without making AI a required dependency.
Regional requirements can be introduced as bounded packs — for example Saudi, UK and EU interoperability obligations — without rewriting the core platform model.
Each integration should move through a predictable lifecycle: identify the profile, map it to the canonical model, validate it, test it, observe it and only then consider production readiness.
Organisation, use case, source system, profile and jurisdiction.
Translate external semantics into a stable internal contract without mutating source meaning.
Check structure, required fields, terminology, identity and provenance expectations.
Run deterministic conformance and workflow tests before real deployment.
Measure delivery, failures, retries, acknowledgements and audit evidence.
Move to production only when contractual, security and technical gates are satisfied.
Integration readiness should be expressed through concrete profiles, launch context, terminology and validation expectations—not a generic FHIR badge.
PROFILE-LEDHL7 v2 interfaces can be wrapped by explicit adapters, acknowledgements, retry rules and mappings into the canonical operating model.
ADAPTER-BOUNDImaging integrations should retain study/series/object identity and provenance while separating transport from clinical interpretation.
PROVENANCE-AWARESAML/OIDC/SCIM establish identity and lifecycle context; organisation, product and record access remain separate decisions.
CONTEXTUAL ACCESSA production transition should require successful validation, controlled test evidence, ownership, rollback/recovery expectations and an explicit organisation approval state.
NeuraOps is structured so hospitals can connect existing systems while keeping policy, workflow state and evidence explicit.